Breast cancer stem cells, EMT and therapeutic targets

Holmes, 2011, Breast cancer: overview & updates, Nurse Pract., 36, 20, 10.1097/01.NPR.0000407602.29522.d7 Morel, 2008, Generation of breast cancer stem cells through epithelial–mesenchymal transition, PLoS One, 3, e2888, 10.1371/journal.pone.0002888 Chuthapisith, 2010, Breast cancer chemoresistance: emerging importance of cancer stem cells, Surg. Oncol., 19, 27, 10.1016/j.suronc.2009.01.004 Kai, 2010, Breast cancer stem cells, Breast Cancer, 17, 80, 10.1007/s12282-009-0176-y Pinto, 2013, Breast cancer stem cells and epithelial mesenchymal plasticity – implications for chemoresistance, Cancer Lett., 341, 56, 10.1016/j.canlet.2013.06.003 Liu, 2014, Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts, Stem Cell Rep., 2, 78, 10.1016/j.stemcr.2013.11.009 Huber, 2005, Molecular requirements for epithelial–mesenchymal transition during tumor progression, Curr. Opin. Cell Biol., 17, 548, 10.1016/j.ceb.2005.08.001 Wang, 2011, Epithelial–mesenchymal transition in breast cancer progression and metastasis, Chin. J. Cancer, 30, 603, 10.5732/cjc.011.10226 Yook, 2006, A Wnt–Axin2–GSK3bold beta cascade regulates Snail1 activity in breast cancer cells, Nat. Cell Biol., 8, 1398, 10.1038/ncb1508 Min, 2008, NF-kappa B and epithelial to mesenchymal transition of cancer, J. Cell. Biochem., 104, 733, 10.1002/jcb.21695 Wu, 2009, Stabilization of snail by NF-kappa B is required for inflammation-induced cell migration and invasion, Cancer Cell, 15, 416, 10.1016/j.ccr.2009.03.016 Leong, 2007, Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin, J. Exp. Med, 204, 2935, 10.1084/jem.20071082 Collu, 2007, Cooperation between Wnt and Notch signalling in human breast cancer, Breast Cancer Res., 9, 105, 10.1186/bcr1671 de Caestecker, 2000, Role of transforming growth factor-β Signaling in cancer, J. Natl Cancer Inst., 92, 1388, 10.1093/jnci/92.17.1388 Gotzmann, 2004, Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis, Mutat. Res., 566, 9, 10.1016/S1383-5742(03)00033-4 Nigam, 2013, Breast cancer stem cells, pathways and therapeutic perspectives 2011, Indian J. Surg., 75, 170, 10.1007/s12262-012-0616-3 Chang, 2013, The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors, Breast Cancer Res., 15, R39, 10.1186/bcr3423 Rustighi, 2014, Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast, EMBO Mol. Med., 6, 99, 10.1002/emmm.201302909 Luo, 2014, Prolylisomerase Pin1 acts downstream of miR-200 to promote cancer stem-like cell traits in breast cancer, Cancer Res., 74, 3603, 10.1158/0008-5472.CAN-13-2785 Wanngren, 2014, Changed membrane integration and catalytic site conformation are two mechanisms behind the increased Aβ42/Aβ40 ratio by presenilin 1 familial Alzheimer-linked mutations, 4, 393 Lombardo, 2012, Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo, Proc. Natl. Acad. Sci. U.S.A., 109, 16558, 10.1073/pnas.1206268109 Filipović, 2011, Biological and clinical implications of nicastrin expression in invasive breast cancer, Breast Cancer Res. Treat., 125, 43, 10.1007/s10549-010-0823-1 Lombardo, 2014, Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells, Breast Cancer Res., 26, R62, 10.1186/bcr3675 Fu, 2014, A novel oncogenic role of inositol phosphatase SHIP2 in ER-Negative breast cancer stem cells: involvement of JNK/Vimentin activation, Stem Cells, 32, 2048, 10.1002/stem.1735 Foulkes, 2010, Triple-negative breast cancer, N. Engl. J. Med., 363, 1938, 10.1056/NEJMra1001389 Cleator, 2007, Triple-negative breast cancer: therapeutic options, Lancet Oncol., 8, 235, 10.1016/S1470-2045(07)70074-8 Kim, 2014, SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model, Oncogene Malhotra, 2011, Shared signaling pathways in normal and breast cancer stem cells, J. Carcinog., 10, 38, 10.4103/1477-3163.91413 Marotta, 2011, The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24− stem cell-like breast cancer cells in human tumors, 121, 2723 Yip, 2006, Therapeutic value of glycosaminoglycans in cancer, Mol. Cancer Ther., 5, 2139, 10.1158/1535-7163.MCT-06-0082 Liu, 2004, The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells, 101, 4158 Ibrahim, 2013, Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling, PLoS One, 8, e85737, 10.1371/journal.pone.0085737 Ibrahim, 2013, Syndecan-1 (CD138) modulates breast cancer stem cell properties via regulation of IL-6-mediated STAT3 signaling, 121, OP3_20 BoDu, 2013, Non-coding RNAs regulate tumor cell plasticity, Sci. Chin. Life Sci., 56, 886, 10.1007/s11427-013-4554-5 Mouw, 2014, Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression, Nat. Med., 20, 360, 10.1038/nm.3497 Martin, 2014, Multidrug-resistant breast cancer: current perspectives, Breast Cancer, 6, 1 Hwang-Verslues, 2011, MiR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1, Oncogene, 30, 2463, 10.1038/onc.2010.618 Wang, 2011, Transforming growth factor β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM, Oncogene, 30, 1470, 10.1038/onc.2010.531 Wang, 2013, MiRNA-205 affects infiltration and metastasis of breast cancer, Biochem. Biophys. Res. Commun., 441, 139, 10.1016/j.bbrc.2013.10.025 Zhang, 2014, A family of pleiotropically acting microRNAs in cancer progression, miR-200: potential cancer therapeutic targets, Curr. Pharm. Des., 20, 1896, 10.2174/13816128113199990519 Bai, 2014, MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer, Int. J. Cancer, 10.1002/ijc.28782 Kopp, 2012, MiR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression, PLoS One, 7, e50469, 10.1371/journal.pone.0050469 Jiang, 2014, Restoration of MiR-17/20a in solid tumor cells enhances the natural killer cell anti-tumor activity by targeting Mekk2, Cancer Immunol. Res., 2, 789, 10.1158/2326-6066.CIR-13-0162 Yu, 2010, MiR-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells, Oncogene, 29, 4194, 10.1038/onc.2010.167 Yu, 2007, Let-7 regulates self renewal and tumorigenicity of breast cancer cells, Cell, 131, 1109, 10.1016/j.cell.2007.10.054 Johnson, 2007, The let-7 microRNA represses cell proliferation pathways in human cells, Cancer Res., 67, 7713, 10.1158/0008-5472.CAN-07-1083 Kumar, 2008, Suppression of non-small cell lung tumor development by the let-7 microRNA family, Proc. Natl. Acad. Sci. U.S.A., 105, 3903, 10.1073/pnas.0712321105 Wang, 2012, Genomic DNA copy-number alterations of the let-7 family in human cancers, PLoS One Yu, 2012, MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells, J. Biol. Chem., 287, 465, 10.1074/jbc.M111.280768 Schwarzenbacher, 2013, The Role of MicroRNAs in breast cancer stem cells, Int. J. Mol. Sci., 14, 14712, 10.3390/ijms140714712 Zhu, 2011, Reduced miR-128 in breast tumor-initiating cells induces chemotherapeutic resistance via Bmi-1 and ABCC5, Clin. Cancer Res., 17, 7105, 10.1158/1078-0432.CCR-11-0071 Zhang, 2010, Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway, Cancer Res., 70, 7176, 10.1158/0008-5472.CAN-10-0697 Mackiewicz, 2011, Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA, Breast Cancer Res. Treat., 130, 663, 10.1007/s10549-011-1690-0 Sun, 2010, Microarray-based analysis of microRNA expression in breast cancer stem cells, J. Exp. Clin. Cancer Res., 29, 174, 10.1186/1756-9966-29-174